Form 4: Health Catalyst CEO Buys Shares
Insider Transaction (Form 4)
Simeon Kohl, Chief Executive Officer and a Director of Health Catalyst, Inc., purchased 59,000 shares of common stock on September 14, 2026 for $1.79 per share.
Summary
- Grant/award: acquired 2,747,385 Common Stock on September 14, 2026; holds 2,797,385 after (Direct).
- Open-market purchase: acquired 59,000 Common Stock at $1.79 ($105,439) on September 14, 2026; holds 2,856,385 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $105,439, committing personal capital to the stock.
Insider Transactions
Simeon Kohl — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-14 | Grant/award | Common Stock | 2,747,385 | — | — | 2,797,385 |
| 2026-09-14 | Open-market purchase | Common Stock | 59,000 | $2 | $105.4K | 2,856,385 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-14 | Grant/award (2,747,385 shares) |
| 2026-09-14 | Open-market purchase (59,000 shares) |
Keywords
insider transaction, Form 4, HCAT, Health Catalyst, Inc., bullish, Simeon Kohl
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.